Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

Advice Statement

  • Home
  • Our Advice
  • Robot assisted laparoscopic partial nephrectomy in patients with T1a or T1b renal cancer

Title

Output Type

Speciality

Published

Title

Robot assisted laparoscopic partial nephrectomy in patients with T1a or T1b renal cancer

Output Type

Advice Statement

Speciality

Cancer, Digestive System, Genitourinary system

Published

18 January 2018

Recommendation for NHSScotland

Evidence is of insufficient quality to reach conclusions on the comparative clinical effectiveness and long-term cost effectiveness of robot assisted laparoscopic partial nephrectomy, open partial nephrectomy and conventional laparoscopic partial nephrectomy. Reported benefits for the robotic procedure are based on short-term non-randomised studies which do not report long-term clinical outcomes. In a single retrospective UK study the robot assisted laparoscopic procedure was associated with a statistically significant reduction in the costs associated with 90-day complication rates and 1-year hospital activity when compared with open partial nephrectomy.

What were we asked to look at?

What is the clinical and cost-effectiveness of robot assisted laparoscopic partial nephrectomy compared with open or conventional laparoscopic procedures in patients with
T1a or T1b renal cancer? 

Why is this important?

Da Vinci robotic surgical devices are a relatively new technology which is available at three centres in NHSScotland. These devices are currently used predominantly to
provide a laparoscopic prostatectomy service. To ensure the devices are optimally employed, NHSScotland is considering expanding the indications for which robotic
surgery is available. This work was accepted onto the SHTG programme as a priority, to support evidence-informed use of robotic surgery capacity.

Referred by

West of Scotland Cancer Network

Download icon
Download Advice
pdf (368 KB)
Download icon
Download Evidence Note
pdf (740 KB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?